Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
61
NMPA:61
Drug Approvals
Azithromycin for Suspension
- Product Name
- 阿奇霉素干混悬剂
- Approval Number
- 国药准字H20249662
- Approval Date
- Dec 1, 2024
NMPA
Sacubitril Valsartan Sodium Tablets
- Product Name
- 沙库巴曲缬沙坦钠片
- Approval Number
- 国药准字H20244992
- Approval Date
- Sep 26, 2024
NMPA
Solifenacin Succinate Tablets
- Product Name
- 琥珀酸索利那新片
- Approval Number
- 国药准字H20244345
- Approval Date
- Jun 28, 2024
NMPA
Donepezil Hydrochloride Orally Disintegrating Tablets
- Product Name
- 盐酸多奈哌齐口崩片
- Approval Number
- 国药准字H20243639
- Approval Date
- Apr 30, 2024
NMPA
Donepezil Hydrochloride Orally Disintegrating Tablets
- Product Name
- 盐酸多奈哌齐口崩片
- Approval Number
- 国药准字H20243640
- Approval Date
- Apr 30, 2024
NMPA
Itopride Hydrochloride Tablets
- Product Name
- 盐酸伊托必利片
- Approval Number
- 国药准字H20233708
- Approval Date
- Jun 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found